{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:32Z","timestamp":1794047492220,"version":"4.8.0"},"reference-count":52,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Resistance to chemotherapy remains a major hurdle to the cure of patients with acute myeloid leukemia (AML). Recent studies indicate that a minority of malignant cells, termed drug-tolerant persisters (DTP), stochastically upregulate stress pathways to evade cell death upon acute exposure to chemotherapy without acquiring new genetic mutations. This chemoresistant state is transient and the cells return to the baseline state after removal of chemotherapy. Nevertheless, the mechanisms employed by DTP to resist chemotherapy are not well understood and it is largely unknown whether these mechanisms are also seen in patients receiving chemotherapy. Here, we used leukemia cell lines, primary AML patients\u2019 samples and samples from patients with AML receiving systemic chemotherapy to study the DTP state. We demonstrated that a subset of AML cells transiently increases membrane rigidity to resist killing due to acute exposure to daunorubicin and Ara-C. Upon removal of the chemotherapy, membrane rigidity returned to baseline and the cells regained chemosensitivity. Although resistant to chemotherapy, the increased membrane rigidity rendered AML cells more susceptible to T-cell-mediated killing. Thus, we identified a novel mechanism by which DTP leukemic cells evade chemotherapy and a strategy to eradicate these persistent cells.<\/jats:p>","DOI":"10.3324\/haematol.2024.286018","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T11:03:13Z","timestamp":1732186993000},"page":"893-903","source":"Crossref","is-referenced-by-count":8,"title":["Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing"],"prefix":"10.3324","volume":"110","author":[{"given":"Yael","family":"Morgenstern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JongBok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoosu","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon Y.","family":"Lieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Gwynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Hurren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakai","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Gronda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraham","family":"Frisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsila","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishai","family":"Ofran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Quaile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Rafael","family":"Montenegro-Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Schimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"74087","doi-asserted-by":"crossref","unstructured":"Ferguson P, Hills RK, Grech A. An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation. Haematologica. 2016; 101(11):1351-1358.","DOI":"10.3324\/haematol.2016.148825"},{"key":"74088","doi-asserted-by":"crossref","unstructured":"R\u00fccker FG, Schlenk RF, Bullinger L. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood. 2012; 119(9):2114-2121.","DOI":"10.1182\/blood-2011-08-375758"},{"key":"74089","doi-asserted-by":"crossref","unstructured":"Zeng AGX, Bansal S, Jin L. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia. Nat Med. 2022; 28(6):1212-1223.","DOI":"10.1038\/s41591-022-01819-x"},{"key":"74090","doi-asserted-by":"crossref","unstructured":"Ofran Y, Hayun M, Leiba R. Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: a long-term follow-up of a multi-center prospective study. Am J Hematol. 2020; 95(1):E3-E5.","DOI":"10.1002\/ajh.25651"},{"key":"74091","doi-asserted-by":"crossref","unstructured":"Bertoli S, Bories P, B\u00e9n\u00e9 MC. Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group. Haematologica. 2014; 99(1):46-53.","DOI":"10.3324\/haematol.2013.091819"},{"key":"74092","doi-asserted-by":"crossref","unstructured":"Ding L, Ley TJ, Larson DE. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012; 481(7382):506-510.","DOI":"10.1038\/nature10738"},{"key":"74093","doi-asserted-by":"crossref","unstructured":"Shlush LI, Mitchell A, Heisler L. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature. 2017; 547(7661):104-108.","DOI":"10.1038\/nature22993"},{"key":"74094","doi-asserted-by":"crossref","unstructured":"Parkin B, Ouillette P, Li Y. Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia. Blood. 2013; 121(2):369-377.","DOI":"10.1182\/blood-2012-04-427039"},{"key":"74095","doi-asserted-by":"crossref","unstructured":"Li K, Du Y, Cai Y. Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed\/refractory acute myeloid leukemia. Leukemia. 2023; 37(2):308-325.","DOI":"10.1038\/s41375-022-01789-6"},{"key":"74096","doi-asserted-by":"crossref","unstructured":"Duy C, Li M, Teater M. Chemotherapy induces senescencelike resilient cells capable of initiating AML recurrence. Cancer Discov. 2021; 11(6):1542-1561.","DOI":"10.1158\/2159-8290.CD-20-1375"},{"key":"74097","doi-asserted-by":"crossref","unstructured":"Farge T, Saland E, de Toni F. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 2017; 7(7):716-735.","DOI":"10.1158\/2159-8290.CD-16-0441"},{"key":"74098","doi-asserted-by":"crossref","unstructured":"Boyd AL, Aslostovar L, Reid J. Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence. Cancer Cell. 2018; 34(3):483-498.e5.","DOI":"10.1016\/j.ccell.2018.08.007"},{"key":"74099","doi-asserted-by":"crossref","unstructured":"van Gastel N, Spinelli JB, Sharda A. Induction of a timed metabolic collapse to overcome cancer chemoresistance. Cell Metab. 2020; 32(3):391-403.e6.","DOI":"10.1016\/j.cmet.2020.07.009"},{"key":"74100","doi-asserted-by":"crossref","unstructured":"Dhimolea E, de Matos Simoes R, Kansara D. An embryonic diapause-like adaptation with suppressed Myc activity enables tumor treatment persistence. Cancer Cell. 2021; 39(2):240-256.e11.","DOI":"10.1016\/j.ccell.2020.12.002"},{"key":"74101","doi-asserted-by":"crossref","unstructured":"Vinogradova M, Gehling VS, Gustafson A. An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells. Nat Chem Biol. 2016; 12(7):531-538.","DOI":"10.1038\/nchembio.2085"},{"key":"74102","doi-asserted-by":"crossref","unstructured":"Rehman SK, Haynes J, Collignon E. Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy. Cell. 2021; 184(1):226-242.e21.","DOI":"10.1016\/j.cell.2020.11.018"},{"key":"74103","doi-asserted-by":"crossref","unstructured":"Ramirez M, Rajaram S, Steininger RJ. Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells. Nat Commun. 2016; 7:10690.","DOI":"10.1038\/ncomms10690"},{"key":"74104","doi-asserted-by":"crossref","unstructured":"Sharma SV, Lee DY, Li B. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell. 2010; 141(1):69-80.","DOI":"10.1016\/j.cell.2010.02.027"},{"key":"74105","doi-asserted-by":"crossref","unstructured":"Oren Y, Tsabar M, Cuoco MS. Cycling cancer persister cells arise from lineages with distinct programs. Nature. 2021; 596(7873):576-582.","DOI":"10.1038\/s41586-021-03796-6"},{"key":"74106","doi-asserted-by":"crossref","unstructured":"Li S, Song Y, Quach C. Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance. Nat Commun. 2019; 10(1):1693.","DOI":"10.1038\/s41467-019-09634-8"},{"key":"74107","doi-asserted-by":"crossref","unstructured":"Aloia A, M\u00fcllhaupt D, Chabbert CD. A fatty acid oxidationdependent metabolic shift regulates the adaptation of BRAF-mutated melanoma to MAPK Inhibitors. Clin Cancer Res. 2019; 25(22):6852-6867.","DOI":"10.1158\/1078-0432.CCR-19-0253"},{"key":"74108","doi-asserted-by":"crossref","unstructured":"Viale A, Pettazzoni P, Lyssiotis CA. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature. 2014; 514(7524):628-632.","DOI":"10.1038\/nature13611"},{"key":"74109","doi-asserted-by":"crossref","unstructured":"Dinic J, Biverst\u00e5hl H, M\u00e4ler L, Parmryd I. Laurdan and di-4-ANEPPDHQ do not respond to membrane-inserted peptides and are good probes for lipid packing. Biochim Biophys Acta. 2011; 1808(1):298-306.","DOI":"10.1016\/j.bbamem.2010.10.002"},{"key":"74110","doi-asserted-by":"crossref","unstructured":"Harayama T, Riezman H. Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol. 2018; 19(5):281-296.","DOI":"10.1038\/nrm.2017.138"},{"key":"74111","doi-asserted-by":"crossref","unstructured":"Cevc G. How membrane chain-melting phase-transition temperature is affected by the lipid chain asymmetry and degree of unsaturation: an effective chain-length model. Biochemistry. 1991; 30(29):7186-7193.","DOI":"10.1021\/bi00243a021"},{"key":"74112","doi-asserted-by":"crossref","unstructured":"Pinto SN, Silva LC, Futerman AH, Prieto M. Effect of ceramide structure on membrane biophysical properties: the role of acyl chain length and unsaturation. Biochim Biophys Acta. 2011; 1808(11):2753-2760.","DOI":"10.1016\/j.bbamem.2011.07.023"},{"key":"74113","doi-asserted-by":"crossref","unstructured":"Prenner E, Honsek G, H\u00f6nig D, M\u00f6bius D, Lohner K. Imaging of the domain organization in sphingomyelin and phosphatidylcholine monolayers. Chem Phys Lipids. 2007; 145(2):106-118.","DOI":"10.1016\/j.chemphyslip.2006.11.002"},{"key":"74114","doi-asserted-by":"crossref","unstructured":"Nirmalanandhan VS, Hurren R, Cameron WD. Increased pressure alters plasma membrane dynamics and renders acute myeloid leukemia cells resistant to daunorubicin. Haematologica. 2015; 100(10):e406-e408.","DOI":"10.3324\/haematol.2015.129866"},{"key":"74115","doi-asserted-by":"crossref","unstructured":"Peetla C, Vijayaraghavalu S, Labhasetwar V. Biophysics of cell membrane lipids in cancer drug resistance: implications for drug transport and drug delivery with nanoparticles. Adv Drug Deliv Rev. 2013; 65(13-14):1686-1698.","DOI":"10.1016\/j.addr.2013.09.004"},{"key":"74116","unstructured":"Ramu A, Glaubiger D, Magrath IT, Joshi A. Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells. Cancer Res. 1983; 43(11):5533-5537."},{"key":"74117","doi-asserted-by":"crossref","unstructured":"Callaghan R, Stafford A, Epand RM. Increased accumulation of drugs in a multidrug resistant cell line by alteration of membrane biophysical properties. Biochim Biophys Acta. 1993; 1175(3):277-282.","DOI":"10.1016\/0167-4889(93)90217-D"},{"key":"74118","doi-asserted-by":"crossref","unstructured":"Shmeeda H, Kaspler P, Shleyer J, Honen R, Horowitz M, Barenholz Y. Heat acclimation in rats: modulation via lipid polyunsaturation. Am J Physiol Regul Integr Comp Physiol. 2002; 283(2):R389-R399.","DOI":"10.1152\/ajpregu.00423.2001"},{"key":"74119","doi-asserted-by":"crossref","unstructured":"Kolomiytseva IK, Perepelkina NI, Zharikova AD, Popov VI. Membrane lipids and morphology of brain cortex synaptosomes isolated from hibernating Yakutian ground squirrel. Comp Biochem Physiol B Biochem Mol Biol. 2008; 151(4):386-391.","DOI":"10.1016\/j.cbpb.2008.08.001"},{"key":"74120","doi-asserted-by":"crossref","unstructured":"Suri LNM, McCaig L, Picardi MV. Adaptation to low body temperature influences pulmonary surfactant composition thereby increasing fluidity while maintaining appropriately ordered membrane structure and surface activity. Biochim Biophys Acta Biomembr. 2012; 1818(7):1581-1589.","DOI":"10.1016\/j.bbamem.2012.02.021"},{"key":"74121","doi-asserted-by":"crossref","unstructured":"Bastiaanse EML, Atsma DE, Vandervalk LJM, Vanderlaarse A. Metabolic inhibition of cardiomyocytes causes an increase in sarcolemmal fluidity which may be due to loss of cellular cholesterol. Arch Biochem Biophys. 1995; 319(2):350-354.","DOI":"10.1006\/abbi.1995.1304"},{"key":"74122","doi-asserted-by":"crossref","unstructured":"Lei K, Kurum A, Kaynak M. Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy. Nat Biomed Eng. 2021; 5(12):1411-1425.","DOI":"10.1038\/s41551-021-00826-6"},{"key":"74123","doi-asserted-by":"crossref","unstructured":"Merims S, Li X, Joe B. Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy. Leukemia. 2011; 25(9):1415-1422.","DOI":"10.1038\/leu.2011.99"},{"key":"74124","doi-asserted-by":"crossref","unstructured":"Lee JB, Minden MD, Chen WC. Allogeneic human double negative T cells as a novel immunotherapy for acute myeloid leukemia and its underlying mechanisms. Clin Cancer Res. 2018; 24(2):370-382.","DOI":"10.1158\/1078-0432.CCR-17-2228"},{"key":"74125","doi-asserted-by":"crossref","unstructured":"Chen B, Lee JB, Kang H, Minden MD, Zhang L. Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy. J Exp Clin Cancer Res. 2018; 37(1):88.","DOI":"10.1186\/s13046-018-0756-9"},{"key":"74126","doi-asserted-by":"crossref","unstructured":"Tang B, Lee JB, Cheng S. Allogeneic double-negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: a first-inhuman phase I study. Am J Hematol. 2022; 97(7):E264-E267.","DOI":"10.1002\/ajh.26564"},{"key":"74127","doi-asserted-by":"crossref","unstructured":"Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019; 36:70-87.","DOI":"10.1016\/j.blre.2019.04.005"},{"key":"74128","unstructured":"Todor IN, Lukyanova NY, Chekhun VF. The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells. Exp Oncol. 2012; 34(2):97-100."},{"key":"74129","doi-asserted-by":"crossref","unstructured":"Liang X, Huang Y. Physical state changes of membrane lipids in human lung adenocarcinoma A549 cells and their resistance to cisplatin. Int J Biochem Cell Biol. 2002; 34(10):1248-1255.","DOI":"10.1016\/S1357-2725(02)00056-0"},{"key":"74130","doi-asserted-by":"crossref","unstructured":"Rebillard A, Tekpli X, Meurette O. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Res. 2007; 67(16):7865-7874.","DOI":"10.1158\/0008-5472.CAN-07-0353"},{"key":"74131","doi-asserted-by":"crossref","unstructured":"Shimolina L, Gulin A, Ignatova N. The role of plasma membrane viscosity in the response and resistance of cancer cells to oxaliplatin. Cancers (Basel). 2021; 13(24):6165.","DOI":"10.3390\/cancers13246165"},{"key":"74132","doi-asserted-by":"crossref","unstructured":"Wieder N, Fried JC, Kim C. FALCON systematically interrogates free fatty acid biology and identifies a novel mediator of lipotoxicity. Cell Metab. 2023; 35(5):887-905.e11.","DOI":"10.1016\/j.cmet.2023.03.018"},{"key":"74133","doi-asserted-by":"crossref","unstructured":"Tirinato L, Pagliari F, Limongi T. An overview of lipid droplets in cancer and cancer stem cells. Stem Cells Int. 2017; 2017:1656053.","DOI":"10.1155\/2017\/1656053"},{"key":"74134","doi-asserted-by":"crossref","unstructured":"May GL, Wright LC, Obbink KG. Increased saturated triacylglycerol levels in plasma membranes of human neutrophils stimulated by lipopolysaccharide. J Lipid Res. 1997; 38(8):1562-1570.","DOI":"10.1016\/S0022-2275(20)37174-1"},{"key":"74135","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang T, Zhang H. Cell softness prevents cytolytic T-cell killing of tumor-repopulating cells. Cancer Res. 2021; 81(2):476-488.","DOI":"10.1158\/0008-5472.CAN-20-2569"},{"key":"74136","doi-asserted-by":"crossref","unstructured":"Tello-Lafoz M, Srpan K, Sanchez EE. Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer. Immunity. 2021; 54(5):1037-1054.","DOI":"10.1016\/j.immuni.2021.02.020"},{"key":"74137","doi-asserted-by":"crossref","unstructured":"Basu R, Whitlock BM, Husson J. Cytotoxic T cells use mechanical force to potentiate target cell killing. Cell. 2016; 165(1):100-110.","DOI":"10.1016\/j.cell.2016.01.021"},{"key":"74138","doi-asserted-by":"crossref","unstructured":"Saitakis M, Dogniaux S, Goudot C. Different TCR-induced T lymphocyte responses are potentiated by stiffness with variable sensitivity. Elife. 2017; 6:23190.","DOI":"10.7554\/eLife.23190"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/11834\/77795","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11834\/78238","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11834\/77795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:07:41Z","timestamp":1794046061000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/11834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.286018","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}